Italian Competition Authority Ends Cartel Proceedings against Seven Suppliers of Radiopharmaceutical Medicines
- 12/06/2024
- News
The Italian competition authority (Autorità Garante della Concorrenza e del Mercato – AGCM) has decided to discontinue an investigation of 7 suppliers of radiopharmaceutical medicines. The decision, adopted on 21 May 2024 and published in the AGCM “bulletin” on 10 June 2024 (see, attachment, at pages 11 and following), is the outcome of a probe of Curium, GE Healthcare, Novartis, that firm’s subsidiary Advanced Accelerator Applications, and others because of suspicions that these parties had divided supply quotas when supplying radiopharmaceutical medicines to public and private hospitals in response to tender proceedings. The case relied on evidence furnished by an unidentified leniency applicant and further proof collected by AGCM during dawn raids. |